Eastland Julia Marie Insider Trades

Insider Trading History

Track insider trading activity for Eastland Julia Marie. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lantheus Holdings
Lantheus Holdings LNTH
Director
Holding Value $825k 8,019 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 4,137 shares
$96.67
$102.82
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
CEO & President
Holding Value $306k 79,133 shares
Last Trade
Feb 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.12k 889 shares
$2.39
$3.87
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
CEO & President
Holding Value $310k 80,022 shares
Last Trade
Feb 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$19.1k 7,866 shares
$2.43
$3.87
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
CEO & President
Holding Value $3M 775,000 shares
Last Trade
Jan 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.2M 775,000 shares
$2.84
$3.87
Lantheus Holdings
Lantheus Holdings LNTH
Director
Holding Value $467k 4,543 shares
Last Trade
May 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$358k 4,543 shares
$78.81
$102.82
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
CEO & President
Holding Value $230k 59,388 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99.8k 59,388 shares
$1.68
$3.87
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
CEO & President
Holding Value $340k 87,888 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$99.8k 59,388 shares
$1.68
$3.87
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
CEO & President
Holding Value $110k 28,500 shares
Last Trade
Jan 31, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$49.3k 28,500 shares
$1.73
$3.87
Zentalis Pharmaceuticals
Zentalis Pharmaceuticals ZNTL
CEO & President
Holding Value $11.7M 3,028,800 shares
Last Trade
Dec 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.1M 3,028,800 shares
$3.66
$3.87
Lantheus Holdings
Lantheus Holdings LNTH
Director
Holding Value $258k 2,506 shares
Last Trade
Sep 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$248k 2,506 shares
$99.08
$102.82
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $349k 22,500 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$267k 22,500 shares
$11.85
$15.50
Harpoon Therapeutics
Harpoon Therapeutics HARP
President And CEO
Holding Value $6.2M 269,381 shares
Last Trade
Mar 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$719k 31,250 shares
$23.01
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
President And CEO
Holding Value $0 0 shares
Last Trade
Mar 11, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$6.62M 312,905 shares
$21.15
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
President And CEO
Holding Value $5.34M 232,003 shares
Last Trade
Jan 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.88M 178,500 shares
$10.55
$23.01
Harpoon Therapeutics
Harpoon Therapeutics HARP
President And CEO
Holding Value $1.23M 53,503 shares
Last Trade
Nov 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$598k 50,000 shares
$11.95
$23.01
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $349k 22,500 shares
Last Trade
May 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$252k 22,500 shares
$11.20
$15.50
Dynavax Technologies
Dynavax Technologies DVAX
Director
Holding Value $166k 10,714 shares
Last Trade
May 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60k 5,357 shares
$11.20
$15.50
Graybug Vision
Graybug Vision GRAY
Director
Holding Value $7.86k 1,429 shares
Last Trade
Mar 23, 2023 Purchase (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.86k 1,429 shares
$5.50
$5.50
CalciMedica
CalciMedica CALC
Director
Holding Value $1.22k 1,429 shares
Last Trade
Mar 23, 2023 Purchase (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.08k 1,429 shares
$5.66
$0.85
CalciMedica
CalciMedica CALC
Director
Holding Value $0 0 shares
Last Trade
Mar 23, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$8.08k 1,429 shares
$5.66
$0.85

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up